Rafael B Blasco

4PUBLICATIONS
42CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Other biological sciences not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 22, 2026
EML4-ALK mediates resistance to KRAS G12C inhibition and induces an oncogenic dependency by rewiring signaling through the wild-type RAS pathway.

|Jan 08, 2025
Endogenous CD4+ T Cells That Recognize ALK and the NPM1::ALK Fusion Protein Can Be Expanded from Human Peripheral Blood.

Serena Stadler, Rafael B Blasco, Vijay Kumar Singh

|Jul 10, 2023
ALK peptide vaccination restores the immunogenicity of ALK-rearranged non-small cell lung cancer.

Ines Mota, Enrico Patrucco, Cristina Mastini

|Dec 14, 2018
Comment on "ALK is a therapeutic target for lethal sepsis".

Rafael B Blasco, Enrico Patrucco, Ines Mota

Pageof 1

Frequent Collaborators

4 joint publications

Roberto Chiarle

2 joint publications

Enrico Patrucco

2 joint publications

Taek-Chin Cheong

2 joint publications

Chiara Ambrogio